CancerREWORKNCT07551453
The Return-to-Work Experience of Cancer Patients: A Descriptive Phenomenological Study
An observational study of Cancer, run by Centro di Riferimento Oncologico - Aviano at 1 site in Italy.
Trial summary
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cancer
- How many people
- 20 participants
- Where
- 1 siteItaly
- Study dates
- 17 Oct 2024to 30 Sep 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population consists of adult cancer patient (18+ years) diagnosed with any primary neoplasm, who are currently employed and undergoing active anticancer treatment (pharmacological, surgical, or radiological) in an outpatient or Day Hospital setting.
Who may be able to join
- Age: 18 years of age or older.
- Diagnosis: Primary diagnosis of neoplasm.
- Treatment: Currently undergoing at least one anticancer treatment (pharmacological/systemic therapy, surgery, or radiotherapy).
- Setting: Patients managed in a Day Hospital or outpatient setting.
- Employment Status: Engaged in paid and continuous professional activity at the time of diagnosis.
- Language: Ability to understand and speak the Italian language fluently.
- Informed Consent: Ability to provide written informed consent for study participation and data processing (privacy) in accordance with local regulations.
Who cannot join
- Pre-existing Unemployment: Individuals who were not employed prior to the onset of the disease.
- Psychiatric or Cognitive Impairment: Current diagnosis of psychiatric disorders or cognitive dysfunction that may interfere with the ability to participate in the interview.
- Terminal Prognosis: Patients with a diagnosis of terminal illness or end-of-life status.
- Lack of Voluntary Consent: Individuals who voluntarily choose not to participate in the project or withdraw consent.
Trial locations and contacts
1 site in 1 country.
About this study
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.
Read the detailed description
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.
- Conditions
- Cancer
- Medical subject headings
- Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Perception of Work Experience and Unmet Health Needs
A qualitative assessment of how cancer patients perceive their professional life during treatment will be carried out using Colaizzi framework (1978). The study uses semi-structured interviews to identify "unexpressed health needs"-specific physical, psychological, or organizational requirements related to working while undergoing therapy that are not currently addressed by standard care.
Measured: up to 1 year
Secondary outcomes (1)
Identification of Potential Nursing Interventions for Work-Related Support
Analysis of patient interviews using a qualitative approach to categorize and define specific nursing actions that can address the work-related health needs identified in the primary objective.
Measured: up to 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2026
- Study start17 Oct 2024
- Primary completion30 Sep 2025
- Study completion30 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centro di Riferimento Oncologico - Aviano
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07551453
- Sponsor's protocol ID
- CRO-2024-051
- Acronym
- REWORK
- Status last verified
- Apr 2026
- First submitted
- 13 Apr 2026
- Last updated
- 24 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Return-to-Work Experience of Cancer Patients: A Descriptive Phenomenological Study
- ClinicalTrials.gov ID
- NCT07551453
- Acronym / sponsor ID
- REWORK / CRO-2024-051
- Conditions
- Cancer
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Centro di Riferimento Oncologico - AvianoUniversity, hospital or other
- Study start
- 17 Oct 2024 (actual)
- Primary completion
- 30 Sep 2025 (actual)
- Study completion
- 30 Sep 2025 (actual)
- First posted
- 24 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.
Detailed description
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of adult cancer patient (18+ years) diagnosed with any primary neoplasm, who are currently employed and undergoing active anticancer treatment (pharmacological, surgical, or radiological) in an outpatient or Day Hospital setting.
Key inclusion criteria (7 listed)
- Age: 18 years of age or older.
- Diagnosis: Primary diagnosis of neoplasm.
- Treatment: Currently undergoing at least one anticancer treatment (pharmacological/systemic therapy, surgery, or radiotherapy).
- Setting: Patients managed in a Day Hospital or outpatient setting.
- Employment Status: Engaged in paid and continuous professional activity at the time of diagnosis.
Key exclusion criteria (4 listed)
- Pre-existing Unemployment: Individuals who were not employed prior to the onset of the disease.
- Psychiatric or Cognitive Impairment: Current diagnosis of psychiatric disorders or cognitive dysfunction that may interfere with the ability to participate in the interview.
- Terminal Prognosis: Patients with a diagnosis of terminal illness or end-of-life status.
- Lack of Voluntary Consent: Individuals who voluntarily choose not to participate in the project or withdraw consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Perception of Work Experience and Unmet Health Needs
Time frame: up to 1 year
A qualitative assessment of how cancer patients perceive their professional life during treatment will be carried out using Colaizzi framework (1978). The study uses semi-structured interviews to identify "unexpressed health needs"-specific physical, psychological, or organizational requirements related to working while undergoing therapy that are not currently addressed by standard care.
1 secondary outcome
Identification of Potential Nursing Interventions for Work-Related Support
Time frame: up to 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Apr 2026.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by Centro di Riferimento Oncologico - Aviano at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Perception of Work Experience and Unmet Health Needs (time frame: up to 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2026.